Kevin Joseph Fitzgerald serves as Executive at ALNYLAM PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Kevin Joseph Fitzgerald has executed 57 insider transactions totaling $13.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 25, 2024 involved selling 227 shares valued at $52.2K.
Kevin Joseph Fitzgerald currently holds 21,264 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Joseph Fitzgerald has been a net seller of ALNY stock. They have purchased $0 and sold $13.5M worth of shares.
Kevin Joseph Fitzgerald's most recent insider trade was on Jun 25, 2024, when they sold 227 shares at $229.93 per share.
Get notified when new Form 4 filings are submitted
| $231.59 |
| Discretionary |
| Jun 25, 2024 | ALNY | $29.4K | Sale | 125 | $235.19 | Discretionary |
| Jun 25, 2024 | ALNY | $32.4K | Sale | 138 | $234.66 | Discretionary |
| Jun 25, 2024 | ALNY | $20.1K | Sale | 86 | $233.53 | Discretionary |
| Jun 25, 2024 | ALNY | $37.4K | Sale | 161 | $232.54 | Discretionary |
| Jun 24, 2024 | ALNY | $0 | Award | 2,498 | $N/A | Discretionary |